| Marguarette Jean Suprien, | |
|
6900 N Pecos Rd, N Las Vegas, NV 89086-4400 | |
| (702) 791-9000 | |
| Not Available |
| Full Name | Marguarette Jean Suprien |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Family |
| Location | 6900 N Pecos Rd, N Las Vegas, Nevada |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1881051415 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | APRN001817 (Nevada) | Primary |
| Entity Name | Cal Psychiatric Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1619255122 PECOS PAC ID: 3870808744 Enrollment ID: O20150821012601 |
News Archive
Alexza Pharmaceuticals, Inc. announced today that it has licensed its Staccato nicotine technology to Cypress Bioscience, Inc. The Staccato nicotine technology is a novel electronic multidose delivery system designed to help people stop smoking. The Staccato nicotine technology is intended to improve on a well-validated smoking cessation approach by delivering nicotine via inhalation, mimicking the nicotine effects of smoking without the harmful side effects associated with cigarettes.
Endomagnetics, the company co-founded in the United Kingdom by a University of Houston researcher to develop products to improve the standard of breast cancer care, has been named one of two winners of an inaugural Nanomedicine Award in the European Union.
Nine years after diagnosis, 9.3 percent of U.S. cancer survivors were current smokers and 83 percent of these individuals were daily smokers who averaged 14.7 cigarettes per day, according to a report in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research (AACR).
New research led by investigators at Massachusetts General Hospital and Massachusetts Eye and Ear indicates that the blood pressure drug losartan may benefit patients with neurofibromatosis type 2 (NF2), a hereditary condition associated with vestibular schwannomas, or noncancerous tumors along the nerves in the brain that are involved with hearing and balance.
› Verified 4 days ago
| Entity Name | Medtrans |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1871915892 PECOS PAC ID: 9739437815 Enrollment ID: O20180806002709 |
News Archive
Alexza Pharmaceuticals, Inc. announced today that it has licensed its Staccato nicotine technology to Cypress Bioscience, Inc. The Staccato nicotine technology is a novel electronic multidose delivery system designed to help people stop smoking. The Staccato nicotine technology is intended to improve on a well-validated smoking cessation approach by delivering nicotine via inhalation, mimicking the nicotine effects of smoking without the harmful side effects associated with cigarettes.
Endomagnetics, the company co-founded in the United Kingdom by a University of Houston researcher to develop products to improve the standard of breast cancer care, has been named one of two winners of an inaugural Nanomedicine Award in the European Union.
Nine years after diagnosis, 9.3 percent of U.S. cancer survivors were current smokers and 83 percent of these individuals were daily smokers who averaged 14.7 cigarettes per day, according to a report in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research (AACR).
New research led by investigators at Massachusetts General Hospital and Massachusetts Eye and Ear indicates that the blood pressure drug losartan may benefit patients with neurofibromatosis type 2 (NF2), a hereditary condition associated with vestibular schwannomas, or noncancerous tumors along the nerves in the brain that are involved with hearing and balance.
› Verified 4 days ago
| Entity Name | Behavioral Health Solutions Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548765258 PECOS PAC ID: 4385998954 Enrollment ID: O20181116002509 |
News Archive
Alexza Pharmaceuticals, Inc. announced today that it has licensed its Staccato nicotine technology to Cypress Bioscience, Inc. The Staccato nicotine technology is a novel electronic multidose delivery system designed to help people stop smoking. The Staccato nicotine technology is intended to improve on a well-validated smoking cessation approach by delivering nicotine via inhalation, mimicking the nicotine effects of smoking without the harmful side effects associated with cigarettes.
Endomagnetics, the company co-founded in the United Kingdom by a University of Houston researcher to develop products to improve the standard of breast cancer care, has been named one of two winners of an inaugural Nanomedicine Award in the European Union.
Nine years after diagnosis, 9.3 percent of U.S. cancer survivors were current smokers and 83 percent of these individuals were daily smokers who averaged 14.7 cigarettes per day, according to a report in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research (AACR).
New research led by investigators at Massachusetts General Hospital and Massachusetts Eye and Ear indicates that the blood pressure drug losartan may benefit patients with neurofibromatosis type 2 (NF2), a hereditary condition associated with vestibular schwannomas, or noncancerous tumors along the nerves in the brain that are involved with hearing and balance.
› Verified 4 days ago
| Entity Name | Medtrans Medical Nevada Casal Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750846549 PECOS PAC ID: 1850632365 Enrollment ID: O20190410002272 |
News Archive
Alexza Pharmaceuticals, Inc. announced today that it has licensed its Staccato nicotine technology to Cypress Bioscience, Inc. The Staccato nicotine technology is a novel electronic multidose delivery system designed to help people stop smoking. The Staccato nicotine technology is intended to improve on a well-validated smoking cessation approach by delivering nicotine via inhalation, mimicking the nicotine effects of smoking without the harmful side effects associated with cigarettes.
Endomagnetics, the company co-founded in the United Kingdom by a University of Houston researcher to develop products to improve the standard of breast cancer care, has been named one of two winners of an inaugural Nanomedicine Award in the European Union.
Nine years after diagnosis, 9.3 percent of U.S. cancer survivors were current smokers and 83 percent of these individuals were daily smokers who averaged 14.7 cigarettes per day, according to a report in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research (AACR).
New research led by investigators at Massachusetts General Hospital and Massachusetts Eye and Ear indicates that the blood pressure drug losartan may benefit patients with neurofibromatosis type 2 (NF2), a hereditary condition associated with vestibular schwannomas, or noncancerous tumors along the nerves in the brain that are involved with hearing and balance.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Marguarette Jean Suprien, 6900 N Pecos Rd, North Las Vegas, NV 89086-4400 Ph: (702) 791-9000 | Marguarette Jean Suprien, 6900 N Pecos Rd, N Las Vegas, NV 89086-4400 Ph: (702) 791-9000 |
News Archive
Alexza Pharmaceuticals, Inc. announced today that it has licensed its Staccato nicotine technology to Cypress Bioscience, Inc. The Staccato nicotine technology is a novel electronic multidose delivery system designed to help people stop smoking. The Staccato nicotine technology is intended to improve on a well-validated smoking cessation approach by delivering nicotine via inhalation, mimicking the nicotine effects of smoking without the harmful side effects associated with cigarettes.
Endomagnetics, the company co-founded in the United Kingdom by a University of Houston researcher to develop products to improve the standard of breast cancer care, has been named one of two winners of an inaugural Nanomedicine Award in the European Union.
Nine years after diagnosis, 9.3 percent of U.S. cancer survivors were current smokers and 83 percent of these individuals were daily smokers who averaged 14.7 cigarettes per day, according to a report in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research (AACR).
New research led by investigators at Massachusetts General Hospital and Massachusetts Eye and Ear indicates that the blood pressure drug losartan may benefit patients with neurofibromatosis type 2 (NF2), a hereditary condition associated with vestibular schwannomas, or noncancerous tumors along the nerves in the brain that are involved with hearing and balance.
› Verified 4 days ago
Elita Pallasigui, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 6900 Pecos Rd, N Las Vegas, NV 89086 Phone: 702-791-9000 | |
Aura Cynthia Truelove, APRN, FNP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1302 W Craig Rd Ste A, N Las Vegas, NV 89032 Phone: 702-473-8380 Fax: 702-473-8383 | |
Stephanie Marie Melcher, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1302 W Craig Rd, N Las Vegas, NV 89032 Phone: 702-657-9555 Fax: 702-657-9040 | |
Lydia Phan Torres, ARNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 2031 Mcdaniel St Ste 140, N Las Vegas, NV 89030 Phone: 702-633-0207 Fax: 702-633-5099 | |
Amy L. J. King, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1302 W Craig Rd Ste A, N Las Vegas, NV 89032 Phone: 702-473-8380 Fax: 702-473-8383 | |
Katrina Dado, Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 6920 Noah Raven St, N Las Vegas, NV 89084 Phone: 702-470-5128 | |
Noriko Takeda, APRN, FNP-C Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 6900 N Pecos Rd, N Las Vegas, NV 89086 Phone: 702-791-9000 |